Catalogo dei prodotti della ricerca

CAVALIERE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.945
EU - Europa 1.149
AS - Asia 488
SA - Sud America 33
AF - Africa 18
OC - Oceania 7
Totale 3.640
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.903
IT - Italia 622
SG - Singapore 213
IN - India 106
IE - Irlanda 93
DE - Germania 82
CN - Cina 75
SE - Svezia 68
GB - Regno Unito 45
BG - Bulgaria 29
FI - Finlandia 28
NL - Olanda 26
CA - Canada 24
JP - Giappone 24
FR - Francia 23
CH - Svizzera 19
UA - Ucraina 19
AR - Argentina 17
BE - Belgio 16
ES - Italia 16
KR - Corea 15
RU - Federazione Russa 15
MX - Messico 14
BR - Brasile 13
EG - Egitto 9
HK - Hong Kong 8
RO - Romania 8
TR - Turchia 8
ID - Indonesia 7
IR - Iran 7
PT - Portogallo 6
SI - Slovenia 6
TW - Taiwan 6
AU - Australia 5
HU - Ungheria 5
ME - Montenegro 5
AE - Emirati Arabi Uniti 4
AL - Albania 3
GD - Grenada 3
GR - Grecia 3
SA - Arabia Saudita 3
TH - Thailandia 3
ZA - Sudafrica 3
AT - Austria 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RS - Serbia 2
TG - Togo 2
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
PE - Perù 1
PL - Polonia 1
TN - Tunisia 1
VN - Vietnam 1
Totale 3.640
Salva come PNG Salva come JPEG
Città #
Fairfield 235
Chandler 180
Ashburn 143
Singapore 143
Rome 140
Woodbridge 98
Dublin 91
New York 87
Seattle 87
Houston 83
Princeton 80
Wilmington 73
Milan 70
Cambridge 66
Dearborn 47
Millbury 40
San Paolo di Civitate 38
Lawrence 37
Plano 34
Ann Arbor 32
Sofia 28
Santa Clara 25
Beijing 23
London 22
San Diego 22
Boston 20
Andover 15
Florence 15
Helsinki 15
Grand Rapids 13
Falls Church 12
Amsterdam 11
Norwalk 11
Ottawa 11
Toronto 11
Bühl 10
Des Moines 10
Rijen 10
Buenos Aires 9
Ravenna 9
Zurich 9
Bari 8
Boardman 8
Los Angeles 8
Naples 8
Palermo 8
Redwood City 8
Berlin 7
Brussels 7
Federal 7
Langhirano 7
Lappeenranta 7
Oak Park 7
Turin 7
Bologna 6
Cairo 6
Catania 6
Galdo 6
Genoa 6
Padova 6
Stockholm 6
Bremen 5
Debrecen 5
Fremont 5
Hefei 5
Hong Kong 5
Nova Gorica 5
Perugia 5
Podgorica 5
Casalecchio di Reno 4
Castelfranco di Sotto 4
Chengdu 4
Dortmund 4
Duncan 4
Guangzhou 4
Hamburg 4
Kunming 4
Kyoto 4
Menlo Park 4
Murcia 4
Perth 4
Phoenix 4
Porto Alegre 4
Romainville 4
Seoul 4
Suita 4
The Bronx 4
Verona 4
Alessandria 3
Ankara 3
Atlanta 3
Bagheria 3
Bengaluru 3
Brescia 3
Busto Arsizio 3
Carrara 3
Falkenstein 3
Guadalajara 3
Jacksonville 3
Jeonju 3
Totale 2.406
Salva come PNG Salva come JPEG
Nome #
Effects of paraprobiotic MIMLh5 in the treatment of chronic rhinopharyngitis 146
Allergic conjunctivitis: current concepts on pathogenesis and management 143
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL) 142
Sensitization to Gibberellin-regulated protein (Peamaclein) among Italian cypress pollen-sensitized patients 139
Management of patients with chronic rhinosinusitis and nasal polyposis in Italy: expert opinion on the diagnostic-therapeutic approach (La gestione del paziente con rinosinusite cronica e poliposi nasale in Italia: expert opinion sul percorso diagnostico-terapeutico) 120
Changes of NGF pathway in allergic rhinoconjunctivitis: a conjunctival allergen challenge study 112
Higher blood eosinophil levels after omalizumab treatment are associated with poorer asthma outcomes 109
Use of balloon catheter dilation and steroid-eluting stent in light and severe rhinosinusitis of frontal sinus: a multicenter retrospective randomized study 92
Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics 78
Recovery of smell sense loss by mepolizumab in a patient allergic to dermatophagoides and affected by chronic rhinosinusitis with nasal polyps 77
Factors reducing omalizumab response in severe asthma 75
Atrial fibrillation in the perioperative period 74
Different skin prick test sensitization patterns do not influence the response to omalizumab in severe asthma 73
The role of allergoids in allergen immunotherapy: from injective to sublingual route 72
Therapeutic applications of capsaicin in upper airways 70
Total versus completion thyroidectomy: a multidimensional evaluation of long-term vocal alterations 69
Characteristics of candidates for allergen immunotherapy. 68
The spectrum of therapeutic activity of mepolizumab 67
A survey on features of allergic rhinitis in children 65
Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis 63
Human nasal immune system: a special site for immune response establishment 58
Size and shape of the inferior vena cava before and after a fluid challenge: a pilot study 58
Relationship between autism and nasal cytology 55
The skin prick test 55
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management 55
Diagnosis of obstructive sleep apnea in patients with allergic and non-allergic rhinitis 55
Adjuvant therapy with tablets containing sodium jaluronate, carbomer and xantam gum for gerd pharyngitis 54
The safety of sublingual immunotherapy, can the rare systemic reactions be prevented? 53
Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a pilot real-life study 53
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy. 52
Clinical and immunological effects of a treatment with desentizating low-dose multicomponents in IgE mediated and non IgE mediated food allergies: observational retrospective pilot study 51
Cypress pollen: an unexpected major sensitizing agent in different regions of Italy. 51
Effects of omalizumab therapy on allergic rhinitis: a pilot study 50
Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis 48
Allergen immunotherapy management during vaccinations: an international survey 48
Use of balloon catheter dilation vs. traditional endoscopic sinus surgery in management of light and severe chronic rhinosinusitis of the frontal sinus: a multicenter prospective randomized study 47
Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications 47
Biologics for chronic rhinosinusitis with nasal polyps 46
Long-term subjective and objective assessment of smell and taste in COVID-19 45
Mepolizumab effectiveness and allergic status in real life 44
Study on the use of focus harmonic scalpel in thyroidectomies. Is it useful also in preserving voice function? 43
Long-term omalizumab efficacy in allergic rhinitis 42
International consensus statement on allergy and rhinology: Allergic rhinitis - 2023 41
Is lingual tonsil a preferential target for processing sublingually administered materials? 41
Correlation between olfactory function, age, sex, and cognitive reserve index in the Italian population 40
Nasal cytology 38
Pollens causing allergy and their monitoring by aerobiology and phenology 38
Omalizumab a new prospective: a nasal polyposis 38
Allergic rhinitis 37
Diagnostic performance of nasal cytology 37
Asthma associated to rhinitis 36
How to predict the outcome of septorhinoplasty? A normative study of ROE and FROI-17 scores 36
Role of invariant natural killer t cells in patients with tonsillar hypertrophy: the tonsil as an immunological organ 33
ENT tests for assessing the allergic patient 32
Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life 31
Role of imaging in allergic rhinology 31
Laboratory tests for allergy diagnosis 29
Advances in chronic rhinosinusitis in 2020 and 2021 28
New scientific synergies to manage patients with severe rhinitis: allergy diagnosis and treatment for ENT specialists 25
The prevalence of complications in chronic allergic rhinitis 25
Targeting neuroinflammation to alleviate chronic olfactory dysfunction in Long COVID: a role for investigating disease-modifying therapy (DMT)? 24
Eosinophilic lingual tonsillitis induced by sublingual immunotherapy: a case series 24
Nasal cytology identifies allergic rhinitis phenotypes for managing allergen immunotherapy in clinical practice 24
null 20
Quantitative MRI Harmonization to Maximize Clinical Impact: The RIN-Neuroimaging Network 19
High-definition 3D exoscope in pediatric otorhinolaryngology: a systematic literature review 18
Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up. 18
Effects of the silica dust on the nasal mucosa of ceramic workers 18
Impact of the COVID-19 pandemic on paediatric otolaryngology: a nationwide study 18
Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics 18
Chronic rhinosinusitis outcome registry (CHRINOSOR): establishment of an international outcome registry driven by mHealth technology 18
Real-life evidence of Mepolizumab treatment in chronic rhinosinusitis with nasal polyps: a multicentric study 17
Does a closed reduction improve aesthetical and functional outcome after nasal fracture? 17
The present and future of allergen immunotherapy in personalized medicine 16
The role of allergen-specific immunotherapy in ENT diseases: a systematic review 16
Therapeutic strategies to prevent the recurrence of nasal polyps after surgical treatment: an update and in vitro study on growth inhibition of fibroblasts 15
Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs 15
Bilateral and ipsilateral central neck dissection in total thyroidectomy: a long term comparison of complications 15
Long-term perspectives on chronic rhinosinusitis with nasal polyps: evaluating recurrence rates after functional endoscopic sinus surgery in the biologics era—a 5-year follow-up study 14
Long-term outcomes and quality of life following parotidectomy for benign disease 12
Multidisciplinary decision-making—italian consensus after two years of real practice on the management of severe uncontrolled CRSwNP by biologics (ITACA Study) 12
Should omalizumab be used in severe asthma/COPD overlap? 12
Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis 10
The impact of antibiotics and steroids on the nasal microbiome in patients with chronic rhinosinusitis: a systematic review according to PICO criteria 10
Systematic Review of Parotid Gland Sarcomas: Multi-Variate Analysis of Clinicopathologic Findings, Therapeutic Approaches and Oncological Outcomes That Affect Survival Rate 9
Perceptual, aerodynamic and acoustic outcomes of surgical technique for sulcus vocalis patients: a systematic review and meta analysis 8
Chronic rhinosinusitis with nasal polyps: a survey on routine management and evaluation of disease control in practice 8
Safety and adverse reactions in subcutaneous allergen immunotherapy: a review 8
Systematic review of parotid gland sarcomas: multi-variate analysis of clinicopathologic findings, therapeutic approaches and oncological outcomes that affect survival rate 8
Normative data for interpreting the SNOT-22 7
Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps? 6
Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with Dupilumab 5
Kurzfristige lebensqualitätsbewertung nach nasennebenhöhlenoperation bei chronischer rhinosinusitis [Short-term quality of life assessment after sinus surgery for chronic rhinosinusitis] 4
Perioperative management of patients affected by ischemic cardiomyopathy 3
Quantitative MRI Harmonization to Maximize Clinical Impact: The RIN-Neuroimaging Network 1
Totale 4.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.467
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 12 13 32 79 72 42 54 32 34 26
2020/2021362 34 32 57 18 20 8 38 32 23 47 29 24
2021/2022603 19 30 42 36 76 21 14 71 68 37 71 118
2022/2023850 126 107 59 73 56 65 88 68 69 24 74 41
2023/20241.040 37 101 81 68 138 174 57 75 46 82 98 83
2024/2025329 84 90 155 0 0 0 0 0 0 0 0 0
Totale 4.047